Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures

Epilepsia

Volumn 51, Issue 6, 2010, Pages 951-957

  Krauss, Gregory ^a   Ben Menachem, Elinor ^b   Mameniskiene, Ruta ^c   Vaiciene Magistris, Nerija ^d   Brock, Melissa ^e   Whitesides, John G ^e   Johnson, Martin E ^e  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c VILNIUS UNIVERSITY   (Lithuania)

^d KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

^e UCB PHARMA   (Belgium)

Author keywords

Antiepileptic drugs; Epilepsy; Intravenous; Lacosamide; Partial seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; HARKOSERIDE; LAMOTRIGINE; VALPROIC ACID;

ADULT; AGED; ARTICLE; BLURRED VISION; CLINICAL TRIAL; CONSTIPATION; DIPLOPIA; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FOCAL EPILEPSY; HEADACHE; HUMAN; INJECTION SITE CELLULITIS; INJECTION SITE ERYTHEMA; INJECTION SITE EXTRAVASATION; INJECTION SITE INFECTION; INJECTION SITE IRRITATION; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; SOMNOLENCE; UPPER ABDOMINAL PAIN; XEROSTOMIA;

ACETAMIDES; ADMINISTRATION, ORAL; ADULT; AGED; COHORT STUDIES; DIPLOPIA; DRUG ADMINISTRATION SCHEDULE; EPILEPSIES, PARTIAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INTERNATIONALITY; MALE; MIDDLE AGED; SEIZURES; YOUNG ADULT;

EID: 77952781301     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02463.x     Document Type: Article

References (11)

1. Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. (2007) Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48:1308-1317. (Pubitemid 47063096)
2. Beyreuther BK, Freitag J, Heers C, Krebsfänger N, Scharfenecker U, Stöhr T. (2007) Lacosamide: a review of preclinical properties. CNS Drug Rev 13(1):21-42.
3. Bialer M, Johannessenb SI, Levyc RH, Peruccad E, Tomsone T, White SH. (2009) Progress report on new antiepileptic drugs: a Summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res 83:1-43.
4. Biton V, Rosenfeld WE, Whitesides J, Fountain NB, Vaiciene N, Rudd GD. (2008) Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 49:418-424. (Pubitemid 351294527)
5. Chung S, Sperling M, Biton V, Krauss G, Hebert D, Rudd D, Doty D. (2009) Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia, In press.
6. Errington AC, Stöhr T, Heers C, Lees G. (2008) The investigational anti-convulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 73(1):157-169. (Pubitemid 350294207)
7. Halász P, Kälviäinen R, Mazurkiewicz-Beldzińska M, Rosenow F, Doty P, Hebert D, Sullivan T. (2009) Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 50:443-453.
8. Halford JJ, Lapointe M. (2009) Clinical perspectives on lacosamide. Epilepsy Curr 9(1):1-9.
9. Kropeit D, Schiltmeyer B, Cawello W, Hammes W, Horstmann R. (2004) Bioequivalence of short-time infusions compared to oral administration of lacosamide. (Abstract). Epilepsia 45:123.
10. Stöhr T, Kupferberg HJ, Stables JP, Choi D, Harris RH, Kohn H, Walton N, White HS. (2007) Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Epilepsy Res 74(2-3):147-154.
11. Wheless JW, Venkataraman V. (1999) New formulations of drugs in epilepsy. Expert Opin Pharmacother 1:49-60.